妊娠相关急性肾损伤的病理生理机制
妊娠相关急性肾损伤(PrAKI)全球发病率约40-100/万次妊娠,中低收入国家更高。其发生源于妊娠期血流动力学适应、免疫耐受、激素调节及胎儿-胎盘单元等独特生理背景,机制涉及血流动力学、胎盘缺血、免疫与补体失调等多因素,并带来母胎远期肾脏与心血管后果。
要点
- PrAKI全球发病率约40-100/万次妊娠,中低收入国家更常见。
- 妊娠期血管扩张和GFR升高降低肾储备,易感低血容量和脓毒症。
- 胎盘缺血释放sFlt-1和可溶性内皮糖蛋白,致内皮功能障碍和肾小球内皮增生。
核心结论
- PrAKI由妊娠特有血流动力学、免疫、激素及胎盘因素共同驱动,并增加母体CKD和心血管风险及子代远期肾脏心血管疾病风险。
研究设计与样本
- 综述,总结妊娠相关急性肾损伤的病理生理机制。
主要发现
- 妊娠期血管扩张和GFR升高降低肾功能储备,使肾脏易受低血容量和脓毒症打击。
- 胎盘缺血释放sFlt-1和可溶性内皮糖蛋白,引起全身内皮功能障碍和肾小球内皮增生。
- 免疫耐受破坏和补体调节异常促进微血管病和自身免疫介导肾损伤。
- PrAKI后适应不良修复促进CKD和远期心血管风险;胎儿暴露于尿毒症毒素和胎盘功能障碍致宫内生长受限、早产和肾单位减少。
关键数值与推荐
- PrAKI估计发病率为40-100/10 000次妊娠。
临床怎么用
- 理解内皮、免疫和胎盘相互作用对PrAKI诊断和治疗有直接意义,包括使用血管生成生物标志物和针对性血流动力学策略。
局限性
- 未来研究需优先分子预测因子、全球注册和机制研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Pregnancy-associated acute kidney injury (PrAKI) remains a major contributor to maternal and fetal morbidity worldwide, with an estimated incidence of 40-100 per 10 000 pregnancies. PrAKI is substantially more prevalent in low- and middle-income countries. Unlike AKI episodes unrelated to pregnancy, PrAKI arises in a unique physiological context characterized by haemodynamic adaptation, immune tolerance, hormonal modulation, and the presence of the fetal-placental unit. These pregnancy-specific factors alter renal reserve, endothelial stability, and inflammatory responsiveness. The pathogenesis of PrAKI is multifactorial. Haemodynamic vasodilation and increased glomerular filtration rates during pregnancy reduce renal functional reserve, rendering the kidney vulnerable to hypovolemia and sepsis. Placental ischemia drives the release of antiangiogenic factors, particularly soluble fms-like tyrosine kinase-1 (sFlt-1) and soluble endoglin, causing systemic endothelial dysfunction and glomerular endotheliosis. Disruption of immune tolerance and complement regulation further contributes to microangiopathy and autoimmune-mediated renal injury. Structural urinary tract changes, metabolic stressors, and maternal comorbidities amplify susceptibility. Beyond the index event, PrAKI has lasting consequences. Maladaptive renal repair promotes chronic kidney disease and long-term cardiovascular risk, while fetal exposure to uremic toxins and placental dysfunction contribute to intrauterine growth restriction, prematurity, and reduced nephron mass with lifelong cardio-renal implications. Understanding the pathophysiology of PrAKI, particularly endothelial, immunologic, and placental interactions, has direct diagnostic and therapeutic implications, including the use of angiogenic biomarkers and targeted haemodynamic strategies. Future research must prioritize molecular predictors, global registries, and mechanistic studies to reduce intergenerational kidney and cardiovascular disease.
引用
- Kashani KB, Wium L, Ostermann M, et al. Pathophysiology of pregnancy-associated acute kidney injury. Nephrol Dial Transplant. 2026. PMID: 42335947. doi:10.1093/ndt/gfag142
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。